+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2020 Update

  • ID: 5240141
  • Company Profile
  • January 2021
  • 35 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic Plc
  • Novo Nordisk AS
  • MORE
Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ypsomed Holding AG
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic Plc
  • Novo Nordisk AS
  • MORE
Ypsomed Holding AG Company Overview
  • Ypsomed Holding AG Company Snapshot
  • Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview
  • Ypsomed Holding AG - Pipeline Analysis Overview
  • Business Description
  • Ypsomed Holding AG - Key Facts
  • Ypsomed Holding AG - Major Products and Services
  • Ypsomed Holding AG Pipeline Products by Development Stage
Ypsomed Holding AG Pipeline Products Overview
  • Lanzi
  • Lanzi Product Overview
  • Mylife Aveo
  • Mylife Aveo Product Overview
  • mylife YpsoPod Insulin Pump - Tubeless
  • mylife YpsoPod Insulin Pump - Tubeless Product Overview
  • mylife YpsoPump
  • mylife YpsoPump Product Overview
  • mylife YpsoPump 2.0 With Integrated CGM
  • mylife YpsoPump 2.0 With Integrated CGM Product Overview
  • YpsoDose
  • YpsoDose Product Overview
Ypsomed Holding AG - Key Competitors

Ypsomed Holding AG - Key Employees
  • Ypsomed Holding AG - Key Employee Biographies
Ypsomed Holding AG - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Ypsomed Holding AG, Recent Developments
  • Nov 05, 2019: Ypsomed grows strongly in the pen business
  • Oct 22, 2019: Ypsomed enters new partnerships in diabetes therapy
  • Aug 30, 2019: Ypsomed expands headquarters in Burgdorf
  • Aug 22, 2019: Ypsomed opens production plant in Schwerin
  • May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability
  • May 07, 2019: Teva launches Copaxone with the YpsoMate autoinjector from Ypsomed
  • May 01, 2019: Noble continues to elevate patient access with launch of Its innovative YpsoMate Training Device Platform
  • Feb 14, 2019: NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot supports smart self-medication
  • Nov 06, 2018: Ypsomed grows strongly with own products
  • Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Ypsomed Holding AG Pipeline Products and Ongoing Clinical Trials Overview
  • Ypsomed Holding AG Pipeline Products by Equipment Type
  • Ypsomed Holding AG Pipeline Products by Indication
  • Ypsomed Holding AG, Key Facts
  • Ypsomed Holding AG, Major Products and Services
  • Ypsomed Holding AG Number of Pipeline Products by Development Stage
  • Ypsomed Holding AG Pipeline Products Summary by Development Stage
  • Lanzi - Product Status
  • Lanzi - Product Description
  • Mylife Aveo - Product Status
  • Mylife Aveo - Product Description
  • mylife YpsoPod Insulin Pump - Tubeless - Product Status
  • mylife YpsoPod Insulin Pump - Tubeless - Product Description
  • mylife YpsoPump - Product Status
  • mylife YpsoPump - Product Description
  • mylife YpsoPump 2.0 With Integrated CGM - Product Status
  • mylife YpsoPump 2.0 With Integrated CGM - Product Description
  • YpsoDose - Product Status
  • YpsoDose - Product Description
  • Ypsomed Holding AG, Key Employees
  • Ypsomed Holding AG, Key Employee Biographies
  • Ypsomed Holding AG, Subsidiaries
  • Glossary
List of Figures
  • Ypsomed Holding AG Pipeline Products by Equipment Type
  • Ypsomed Holding AG Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3
  • Eli Lilly and Co
  • Novo Nordisk AS
  • Johnson & Johnson
  • Abbott Laboratories
  • Sanofi
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
Note: Product cover images may vary from those shown
Adroll
adroll